Analysis of circulating tumour DNA in paired plasma and sputum samples of EGFR-mutated NSCLC patients

被引：0
|
作者：
Grech, C. [1 ]
Hackner, K. [2 ]
Strieder, M. [2 ]
Buder, A. [1 ]
Hochmair, M. J. [3 ,4 ]
Filipits, M. [1 ]
Errhalt, P. [2 ]
机构：
[1] Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Inst Canc Res, Vienna, Austria
[2] Karl Landsteiner Univ Hlth Sci, Univ Hosp Krems, Dept Pneumol, Krems, Austria
[3] Otto Wagner Hosp, Dept Resp & Crit Care Med, Vienna, Austria
[4] Otto Wagner Hosp, Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1417P
引用
收藏
页码：578 / 578
页数：1
相关论文
共 50 条
  • [1] Mutation tracking in circulating tumour DNA predicts relapse in completely resected EGFR-mutated NSCLC
    Filipits, M.
    Hochmair, M. J.
    Buder, A.
    Watzka, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Circulating DNA in EGFR-mutated lung cancer
    Singh, Aditi P.
    Li, Shenduo
    Cheng, Haiying
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (18)
  • [3] Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients
    Hackner, Klaus
    Buder, Anna
    Hochmair, Maximilian J.
    Strieder, Matthaeus
    Grech, Christina
    Fabikan, Hannah
    Burghuber, Otto C.
    Errhalt, Peter
    Filipits, Martin
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [4] Clinical analysis of the presence of comutations in patients with EGFR-mutated NSCLC
    Rubio, Jaime
    Santolaya, Carlota
    Fernandez, Marina
    Villalba, Paula Lucia
    Avedillo, Mercedes
    Garcia-Foncillas, Jesus
    Domine, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs
    Leonetti, Alessandro
    Capula, Mjriam
    Minari, Roberta
    Mazzaschi, Giulia
    Gregori, Alessandro
    El Hassouni, Btissame
    Papini, Filippo
    Bordi, Paola
    Verze, Michela
    Avan, Amir
    Tiseo, Marcello
    Giovannetti, Elisa
    CELLS, 2021, 10 (06)
  • [6] Disease Monitoring of EGFR-mutated NSCLC Patients Treated with TKIs via EGFR Status in Circulating ctDNA
    Li, Y.
    Xu, Z.
    Wang, S.
    Zhu, Y.
    Ma, D.
    Mu, Y.
    Ying, J.
    Xing, P.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S445 - S445
  • [7] Liquid and Solid Rebiopsies in EGFR-Mutated NSCLC Patients
    Nunes, D.
    Dansin, E.
    Lamblin, C.
    Wasielewski, E.
    Descarpentries, C.
    Gregoire, V.
    Copin, M. C.
    Escande, F.
    Cortot, A.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2237 - S2238
  • [8] A retrospective analysis of tolerability in EGFR-mutated NSCLC patients who received afatinib
    Koriyama, Haruki
    Yoh, Kiyotaka
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Niho, Seiji
    Ohmatsu, Hironobu
    Goto, Koichi
    ANNALS OF ONCOLOGY, 2015, 26 : 137 - 137
  • [9] Efficacy of dacomitinib in patients with EGFR-mutated NSCLC and brain metastases
    Zhang, Jinyao
    Wang, Yan
    Liu, Ziling
    Wang, Lin
    Yao, Yu
    Liu, Yutao
    Hao, Xue Zhi
    Wang, Jianyang
    Xing, Puyuan
    Li, Junling
    THORACIC CANCER, 2021, 12 (24) : 3407 - 3415
  • [10] Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLC
    Kei Kunimasa
    Kazumi Nishino
    Yoshiharu Sato
    Masahide Mori
    Shoichi Ihara
    Hidekazu Suzuki
    Izumi Nagatomo
    Toru Kumagai
    Toshitaka Morishima
    Fumio Imamura
    Scientific Reports, 12
12345